01 16AstraZeneca Canada Inc.
01 32423279
02 32517629
03 22533423
04 32547077
05 32664275
06 22737400
01 16OLAPARIB
01 4CAPSULE
02 12TABLET
01 32021-10-25
02 32024-03-12
03 22024-07-23
04 32024-11-30
05 32027-10-15
06 22029-10-05
Patent Expiration Date : 2024-11-30
Date Granted : 2015-11-03
Brand Name : LYNPARZA
Patent Number : 2547077
Filing Date : 2004-11-30
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-11-30
Date Granted : 2015-11-03
Patent Expiration Date : 2027-10-15
Date Granted : 2015-03-17
Brand Name : LYNPARZA
Patent Number : 2664275
Filing Date : 2007-10-15
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-10-15
Date Granted : 2015-03-17
Patent Expiration Date : 2021-10-25
Date Granted : 2011-07-05
Brand Name : LYNPARZA
Patent Number : 2423279
Filing Date : 2001-10-25
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-10-25
Date Granted : 2011-07-05
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
Brand Name : LYNPARZA
Patent Number : 2517629
Filing Date : 2004-03-12
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
Patent Expiration Date : 2029-10-05
Date Granted : 2016-11-22
Brand Name : LYNPARZA
Patent Number : 2737400
Filing Date : 2009-10-05
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-10-05
Date Granted : 2016-11-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-10-25
Date Granted : 2011-07-05
Brand Name : LYNPARZA
Patent Number : 2423279
Filing Date : 2001-10-25
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-10-25
Date Granted : 2011-07-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-11-30
Date Granted : 2015-11-03
Brand Name : LYNPARZA
Patent Number : 2547077
Filing Date : 2004-11-30
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-11-30
Date Granted : 2015-11-03
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-10-15
Date Granted : 2015-03-17
Brand Name : LYNPARZA
Patent Number : 2664275
Filing Date : 2007-10-15
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-10-15
Date Granted : 2015-03-17
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
Brand Name : LYNPARZA
Patent Number : 2517629
Filing Date : 2004-03-12
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
Brand Name : LYNPARZA
Patent Number : 2517629
Filing Date : 2004-03-12
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2024-03-12
Date Granted : 2011-07-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
